These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3895824)

  • 1. [Effects of sodium ferulate combined with acetylsalicylic acid on rat platelet aggregation and on modulation of PGI2-TXA2 balance].
    Xu LN; Wang RL; Xu DC
    Yao Xue Xue Bao; 1985 Jan; 20(1):5-9. PubMed ID: 3895824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on mechanism of the antiplatelet effect of sodium ferulate--effect on TXA2/PGI2 balance].
    Xu LN; Xu DC; Zhang BJ; Wang RL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):414-7. PubMed ID: 6242542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of sodium ferulate on platelet aggregation and platelet thromboxane A2 in patients with coronary heart disease].
    Gao SW; Chen ZJ
    Zhong Xi Yi Jie He Za Zhi; 1988 May; 8(5):263-5, 259. PubMed ID: 3197226
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sodium ferulate on C14-arachidonic acid metabolism in rabbit platelets].
    Xu LN; Yu WG; Tian JY
    Zhong Xi Yi Jie He Za Zhi; 1988 Oct; 8(10):614-5, 583. PubMed ID: 3255545
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sodium ferulate is an inhibitor of thromboxane A2 synthetase].
    Wang Z; Gao YH; Huang RS; Zhu GQ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):430-3. PubMed ID: 3218538
    [No Abstract]   [Full Text] [Related]  

  • 8. EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation.
    Tanaka K; Harada Y; Katori M
    Prostaglandins; 1979 Feb; 17(2):235-7. PubMed ID: 375319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of low-dose aspirin on platelet aggregation and the biosynthesis of PGI2 and TXA2 in patients with coronary heart disease].
    Gao SW; Chen ZJ; Tao SQ
    Zhonghua Nei Ke Za Zhi; 1987 Apr; 26(4):209-12, 255. PubMed ID: 3308356
    [No Abstract]   [Full Text] [Related]  

  • 10. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
    Lumley P; Keery RJ; Wharton KA; White BP; Watts IS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():603-6. PubMed ID: 1825385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
    Okuma M
    Nihon Rinsho; 1978 Dec; 36(12):3830-5. PubMed ID: 372621
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins and angioplasty. An experimental study in canine arteries.
    Zollikofer CL; Cragg AH; Einzig S; Castaneda-Zuniga WR; Castaneda F; Rysavy JA; Bruhlmann WF; Shebuski RJ; Amplatz K
    Radiology; 1983 Dec; 149(3):681-5. PubMed ID: 6227930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
    Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of sodium ferulate on malondialdehyde production from the platelets of rats].
    Yin ZZ; Wang JP; Xu LN
    Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):336-9. PubMed ID: 2954394
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.